Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Device
Medical Devices/Diagnostic Equipment

ACTIM OY: Actim PROM Dipstik Recalled Due to False Positive Test Results

Agency Publication Date: April 17, 2024
Share:
Sign in to monitor this recall

Summary

ACTIM OY is recalling approximately 6,471 units of the Actim PROM dipstik, a rapid diagnostic test used to detect the rupture of fetal membranes (PROM) in pregnant women. Testing has revealed that the presence of personal lubricants in a vaginal specimen can interfere with the results, causing the test to show a false positive. This recall affects all serial numbers for the dipstik kits (REF 30831ETUS) distributed across the United States, specifically in Connecticut. Consumers should be aware that incorrect test results could lead to unnecessary medical interventions or misdiagnosis.

Risk

The use of personal lubricants may interfere with the test's immunoassay, producing a false positive result that incorrectly indicates a rupture of the fetal membrane. This could lead to inappropriate clinical management of pregnancy, such as unnecessary hospitalizations or medical procedures.

What You Should Do

  1. Identify if you have the affected product by checking the packaging for 'Actim PROM dipstik', Reference Number '30831ETUS', and UDI/DI '06430030990608'. All serial numbers in distribution are included in this recall.
  2. If you are a healthcare provider, be advised that the presence of personal lubricants during specimen collection can cause false positive results; consider this interference when interpreting PROM test results.
  3. Contact your healthcare provider or the manufacturer, ACTIM OY, at their headquarters in Espoo, Finland, for specific instructions regarding the use of these kits or to discuss potential impacts on previous test results.
  4. For further information or to report concerns, contact the FDA at 1-888-463-6332 (1-888-INFO-FDA) or visit www.fda.gov/medical-devices/medical-device-recalls.

Your Remedy Options

๐Ÿ“‹Other Action

Healthcare provider consultation

How to: Contact your healthcare provider or the manufacturer for further instructions and potential refund

Affected Products

Product: Actim PROM dipstik (6471 kits)
Model / REF:
REF 30831ETUS
UDI/DI 06430030990608
Lot Numbers:
All serial numbers in distribution

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 93845
Status: Active
Manufacturer: ACTIM OY
Sold By: Medical distributors
Manufactured In: Finland
Units Affected: 6471 kits
Distributed To: Connecticut

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.